Axogen, Inc. — Director's Dealing 2013

Aug 21, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2013-08-16

Reporting Person: Mandato Joseph M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-08-16	Common Stock	A	5000	$2.99	Acquired	5000	Direct
2013-08-19	Common Stock	A	10000	$3.00	Acquired	15000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1426392	Indirect

Footnotes

F1: The shares are owned by De Novo. De Novo Management II, LLC is the sole general partner of De Novo. The reporting person is a managing member of De Novo Management II, LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.